Table 4.
Day 0, CY alone |
Day 1, clofarabine → CY, 2 h after end of infusion | ||
---|---|---|---|
End of infusion | 2 h after end of infusion | ||
Fold increase in γH2AX relative to pretreatment | |||
Median | 1.6 | 0.7 | 5.7 |
Range | 0.4-6.2 | 0.6-6.8 | 0.3-38 |
No. of 1.5-fold or greater increase (%) | 5/13 (38) | 3/13 (23) | 12/13 (92) |
No. of 3-fold or greater increase (%) | 2/13 (15) | 1/13 (8) | 7/13 (54) |
Fold increase in cells with sub-2N DNA content | |||
Median | 1.3 | 1.2 | 1.6 |
Range | 0.5-52 | 0.4-90 | 0.2-62 |
No. of 1.5-fold or greater increase (%) | 3/13 (23) | 4/13 (32) | 8/13 (62) |
Where applicable, data are no./total no. of patients in that category.